The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples